4//SEC Filing
Fox Jennifer Lynne 4
Accession 0001367644-23-000123
CIK 0001367644other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 9:22 PM ET
Size
9.2 KB
Accession
0001367644-23-000123
Insider Transaction Report
Form 4
Fox Jennifer Lynne
EVP, Ext Aff, GC, Corp Sec
Transactions
- Award
Common Stock
2023-06-09+24,616→ 129,975 total - Award
Common Stock
2023-06-09+49,231→ 179,206 total - Award
Employee Stock Option (Right to buy)
2023-06-09+49,231→ 98,169 totalExercise: $8.39Exp: 2030-06-08→ Common Stock (49,231 underlying)
Footnotes (3)
- [F1]Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company or the day prior to the annual shareholder meeting; whichever is earlier. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
- [F2]Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to both cumulative revenues and adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.
- [F3]Vests in three equal installments beginning on the day prior to the anniversary date of the grant.
Documents
Issuer
Emergent BioSolutions Inc.
CIK 0001367644
Entity typeother
Related Parties
1- filerCIK 0001914879
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 9:22 PM ET
- Size
- 9.2 KB